Myeloid cell-targeted therapies for solid tumours

S Goswami, S Anandhan, D Raychaudhuri… - Nature Reviews …, 2023 - nature.com
Myeloid cells are the most abundant immune components of the tumour microenvironment,
where they have a variety of functions, ranging from immunosuppressive to …

[HTML][HTML] MDSCs in sepsis-induced immunosuppression and its potential therapeutic targets

W Zhang, X Fang, C Gao, C Song, Y He, T Zhou… - Cytokine & Growth …, 2023 - Elsevier
Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to
infection. In sepsis, a complicated immune response is initiated, which varies over time with …

Peroxynitrite: a multifaceted oxidizing and nitrating metabolite

C Prolo, L Piacenza, R Radi - Current Opinion in Chemical Biology, 2024 - Elsevier
Peroxynitrite, a short-lived and reactive oxidant, emerges from the diffusion-controlled
reaction between the superoxide radical and nitric oxide. Evidence shows that peroxynitrite …

Targeting tumour-reprogrammed myeloid cells: the new battleground in cancer immunotherapy

F De Sanctis, A Adamo, S Canè, S Ugel - Seminars in Immunopathology, 2023 - Springer
Tumour microenvironment is a complex ecosystem in which myeloid cells are the most
abundant immune elements. This cell compartment is composed by different cell types …

G‐CSF/GM‐CSF‐induced hematopoietic dysregulation in the progression of solid tumors

K He, X Liu, RD Hoffman, RZ Shi, GY Lv… - FEBS open …, 2022 - Wiley Online Library
There are two types of abnormal hematopoiesis in solid tumor occurrence and treatment:
pathological hematopoiesis, and myelosuppression induced by radiotherapy and …

[HTML][HTML] Impact of chronic stress on intestinal mucosal immunity in colorectal cancer progression

S Yang, Y Li, Y Zhang, Y Wang - Cytokine & Growth Factor Reviews, 2024 - Elsevier
Chronic stress is a significant risk factor that contributes to the progression of colorectal
cancer (CRC) and has garnered considerable attention in recent research. It influences the …

The paradoxical role of MDSCs in inflammatory bowel diseases: From bench to bedside

F Zhao, W Gong, J Song, Z Shen, D Cui - Frontiers in immunology, 2022 - frontiersin.org
Myeloid-derived suppressor cells (MDSCs) are a group of bone marrow derived
heterogeneous cells, which is known for their immunosuppressive functions especially in …

BETA PRIME: Phase I study of AdAPT-001 as monotherapy and combined with a checkpoint inhibitor in superficially accessible, treatment-refractory solid tumors

S Kesari, A Bessudo, BR Gastman, AP Conley… - Future …, 2022 - Taylor & Francis
AdAPT-001 is an investigational therapy consisting of a replicative type 5 adenovirus armed
with a TGF-β receptor-immunoglobulin Fc fusion trap, designed to neutralize isoforms 1 and …

Inhaled GM-CSF administered during ongoing pneumovirus infection alters myeloid and CD8 T cell immunity without affecting disease outcome

N Debeuf, J Deckers, S Lameire, C Bosteels… - Frontiers in …, 2024 - frontiersin.org
Granulocyte-macrophage colony stimulating factor (GM-CSF) is a pleiotropic cytokine, able
to promote both myelopoiesis and activation of immune cells. Particularly in the lung, GM …

Myeloid cells in the era of cancer Immunotherapy: top 3 unanswered questions

M Chaib, UA Tanveer, L Makowski - Pharmacology & therapeutics, 2023 - Elsevier
Myeloid cells are increasingly being recognized as central players orchestrating or
suppressing antitumor immune responses. With the advent of high-resolution analytical …